Intravenous immunoglobulin and intravenous methylprednisolone as optimal induction treatment in chronic inflammatory demyelinating polyradiculoneuropathy: protocol of an international, randomised, double-blind, placebo-controlled trial (OPTIC)
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Bus, S. R. M.
Rajabally, Y. A.
Hadden, R. D. M.
de Haan, R. J.
de Borgie, C. A. J. M.
Lunn, M. P.
van Schaik, I. N.
Funding for this research was provided by:
Prinses Beatrix Spierfonds (W.OR17-03)
GBS/CIDP Foundation International
Text and Data Mining valid from 2021-02-19
Version of Record valid from 2021-02-19
15 October 2020
29 January 2021
19 February 2021